ALFA Finder| Revenue growth | 31.5% like-for-like growth in FY26, outperforming market by 1.6x. |
|---|---|
| Margins | EBITDA margins expanded 67bps YoY to 4% via better product mix. |
| Demand visibility | Strong visibility across pharma and diagnostics; expanding into new medical segments. |
| Management confidence | Balanced and confident, emphasizing transition from M&A to organic execution. |
Growth
Growth was driven by 31.5% organic like-for-like revenue increase and aggressive MedTech expansion contributing ₹1,000cr annually.
Outlook
FY27 guidance: 23% consolidated revenue growth and 5% EBITDA margins without new acquisitions.
Risks
High minority interest impacts PAT; working capital remains sensitive to MedTech's longer payable cycles.
Earnings Call filed with NSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹2,019.10
- Market cap
- ₹8,796 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 63.1×Sector 54.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Legal & Regulatory
Entero's subsidiary Vasavi Medicare faces an INR 11.87 crore customer default. Vasavi has fully provided for the dues and plans legal recovery action.
- Value
- ₹11.87 Cr
Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Q2 FY27 Results: Net Profit ₹60.7 Cr, Up 65.8% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹2,087 Cr (+32.9% YoY) and net profit of ₹60.7 Cr (+65.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.7 Cr · +65.8% YoY
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.